NCL Calls For FTC, FDA Action To Stem Use Of Unapproved GLP-1s

By Luke Zarzecki / May 5, 2025 at 6:00 PM

A new white paper from the National Consumers League (NCL) floats ways to weed out the growing use of unapproved weight-loss drugs from legitimate products -- calling for reimbursement of FDA-approved versions, stepped up enforcement by FDA against unapproved compounding and a potential new role by the Federal Trade Commission to stop misleading advertising by unapproved online providers.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.